Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

for
HER2 Negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06953882

Phase 2, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

for
Breast Cancer, Cancer of the Breast
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06981208

Recruiting

Support for Bereaved Cancer Caregivers

for
Bereavement, Cancer, Caregiver, Grief
Location: East Lansing MI
Sponsor: Michigan State University

Sex: All

Age: 18+

Code: NCT06662409

Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

for
Malignancy, Immune Related Adverse Events
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 0+

Code: NCT06789601

Phase 1, Phase 2, Recruiting

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Hackensack NJ, Fairfax VA, Madison WI, Houston TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06598800

Phase 1, Recruiting

My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life

for
Cancer, Anxiety, Depressive Symptoms
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05369429

Recruiting

Integrated Cancer Repository for Cancer Research

for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT02012699

Recruiting

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

for
Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07105033

Recruiting

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

for
Breast Cancer, Cancer Survivor, Fatigue, Pain
Location: Morrow GA, Atlanta GA
Sponsor: Clayton State University

Sex: All

Age: 18 - 60

Code: NCT00336089

Recruiting

Study of AUBE00 in Patients With Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Houston TX
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18+

Code: NCT07030959

Phase 1, Recruiting

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

for
Cancer
Location: Jacksonville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT05655494

Recruiting

WashU DIEP Flap Video and Patient Understanding Improvement

for
Breast Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 18+

Code: NCT06864754

Recruiting

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

for
Locally Advanced/Metastatic Solid Tumors
Location: New Haven CT, Indianapolis IN, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06414460

Phase 1, Phase 2, Recruiting

Evaluation of AP-002 in Patients With Solid Tumors

for
Solid Tumor
Location: Saint Louis MO, Houston TX
Sponsor: Altum Pharmaceuticals INC

Sex: All

Age: 18+

Code: NCT04143789

Phase 1, Phase 2, Recruiting

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT06727773

Phase 2, Recruiting

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 15 - 39

Code: NCT06941324

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: New York NY, Philadelphia PA, Norfolk VA, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase 1, Phase 2, Recruiting

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

for
Breast Carcinoma, Neuropathy
Location: Boston MA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT02610439

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial